Author:
Bardenheier Barbara H.,Duderstadt Susan K.,Engler Renata J.M.,McNeil Michael M.
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference38 articles.
1. Centers for Disease Control and Prevention. Safety of influenza A (H1N1) 2009 monovalent vaccines – United States, October 1-November 24, 2009. MMWR Morbidity and mortality weekly report, vol. 58, 2009, pp. 1351–1356.
2. Adverse events following pandemic influenza vaccine Pandemrix(R) reported in the French military forces–2009-2010;Mayet;Vaccine,2011
3. Passive surveillance of adverse events of an MF59-adjuvanted H1N1v vaccine during the pandemic mass vaccinations;Banzhoff;Human Vaccines,2011
4. Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010;Vellozzi;Vaccine,2010
5. Immediate hypersensitivity reactions following monovalent 2009 pandemic influenza A (H1N1) vaccines: reports to VAERS;Halsey;Vaccine,2013